Industry Webcast

Discovering hidden dangers: The critical link between CKD, albuminuria, and cardiovascular riskIndustry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit

Do you have all the pieces of the puzzle to assess cardiovascular (CV) risk in your patients? This interactive program will delve into the evolving understanding of chronic kidney disease (CKD) as a key predictor of CV risk. We will explore tools available to enhance the assessment of CV risk, including clinical testing such as urine-to-albumin creatine ratio (UACR) and risk calculators. This symposium aims to equip attendees with practical, clinically relevant approaches to help identify at-risk individuals in their practices early, with a goal of reducing CV risk.